Overview

Pharmacokinetics of Inhaled Levosimendan

Status:
RECRUITING

Trial end date:
2025-01-01

Target enrollment:

Participant gender:

Summary

Determination of biological availability, time-to-peak and elimination half-life of inhaled levosimendan by administration of an inhaled- and intravenous dose of levosimendan.

Phase:

PHASE2

Details

Lead Sponsor:

Universitair Ziekenhuis Brussel